Näslund, Erik http://orcid.org/0000-0002-4989-1831
Lindberg, Lars-Göran
Lund, Iréne
Näslund-Koch, Lui
Larsson, Agneta
Frithiof, Robert http://orcid.org/0000-0003-2278-7951
Funding for this research was provided by:
Vetenskapsrådet (523-2014-2569)
Article History
Received: 29 November 2018
Accepted: 20 February 2019
First Online: 25 February 2019
Compliance with ethical standards
:
: R. Frithiof has received consulting fees from Matisse Pharmaceuticals. L.-G. Lindberg is a co-owner of a development company, RespiHeart AB, with the intent of commercialisation of the RespiHeart system. The remaining authors declare no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.